a2 Milk Company Ltd (Australia) shares just hit an all-time high

The a2 Milk Company Ltd (Australia) (ASX:A2M) share price hit a new all-time high today. Is it too late to invest?

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Although it finished the day slightly lower, the a2 Milk Company Ltd (Australia) (ASX: A2M) share price reached an all-time high of $7.55 in morning trade.

This stretched the year-to-date gain for the dairy company's shares to a whopping 270%.

Why have its shares been on a tear?

Investors have been fighting to get hold of a2 Milk's shares due to the insatiable demand for its infant formula in the China market.

This demand resulted in sales into China rising from $38.2 million to $88.9 million, and EBITDA from $9.2 million to $32.7 million in FY 2017.

Furthermore, investors appear to be pleased that the company has gained CFDA approval to continue selling its products in the market from January 1 2018 when regulations change.

As things stand, a2 Milk is the only listed Australian company that has been granted approval from Chinese regulators. This could put the company in a solid position to grow its market share in the lucrative market next year.

Should you invest?

Investors won't have to wait long to find out if its recent gains have been justified. Next month a2 Milk will hold its annual general meeting and is widely expected to provide the market with a trading update.

Whilst I think that a2 Milk could be one of the best long-term buy and hold investments on the local market, I believe it would be prudent for investors to hold off an investment until after its annual general meeting.

Considering the incredible run of a2 Milk and its its infant formula peers Bellamy's Australia Ltd (ASX: BAL), Wattle Health Australia Ltd (ASX: WHA), and Bubs Australia Ltd (ASX: BUB), should growth come in lower than expected, there's a chance its shares could come tumbling down.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia owns shares of A2 Milk. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on ⏸️ Investing

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »

⏸️ Investing

Why Fox (NASDAQ:FOX) might hurt News Corp (ASX:NWS) shareholders

News Corporation (ASX: NWS) might be facing some existential threats from its American cousins over the riots on 6 January

Read more »